BSX vs. EHC: Boston Scientific vs. Encompass Health Stock Comparison

Company Profile

Boston Scientific (BSX) and Encompass Health (EHC) both fall under the Health Care Equipment & Services industry group, but BSX is classified in Health Care Equipment & Supplies while EHC is classified in Health Care Providers & Services.

Price Performance

Cumulative Growth

Trailing Returns

Calendar-Year Returns

Performance Metrics

Risk Profile

Drawdown History

Return Distribution

Risk Metrics

Boston Scientific (BSX) is heavily traded at around 19.73M shares per day, whereas Encompass Health (EHC) sees a more moderate 996.79K — larger orders in the latter may require more patience and tighter control over order sizing.

Risk-Adjusted Performance

Risk-Return Positioning

Risk-Adjusted Metrics

Profitability

Encompass Health (EHC) at 25.11% sits in the top ROE quartile, while Boston Scientific (BSX) at 14.12% is closer to the peer norm — stronger capital efficiency for EHC.

For every dollar of sales, both Boston Scientific (BSX) at 16.62% and Encompass Health (EHC) at 10.17% retain more as net profit than most peers, landing in the top net margin quartile of their industries.

Both Boston Scientific (BSX) at 19.05% and Encompass Health (EHC) at 18.07% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.

Profitability Metrics

Growth

Both Boston Scientific (BSX) at 19.87% and Encompass Health (EHC) at 10.46% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.

Boston Scientific (BSX) at 55.20% sits in the top EPS growth quartile, while Encompass Health (EHC) at 24.22% is closer to the peer norm — faster per-share earnings growth for BSX.

Growth Metrics

Financial Strength

Both Boston Scientific (BSX) at 1.37 and Encompass Health (EHC) at 1.09 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.

Both Boston Scientific (BSX) at 0.46 and Encompass Health (EHC) at 0.79 fund their balance sheets with roughly industry-typical debt-to-equity mixes.

Financial Strength Metrics

Dividends

Boston Scientific (BSX) pays no dividend (yield 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Encompass Health (EHC) reports a yield of 0.55%, ranking against industry peers normally.

Boston Scientific (BSX) pays no dividend (payout 0.00%) — it may be reinvesting, using buybacks, or simply not returning cash through dividends. Meanwhile Encompass Health (EHC) reports a payout of 12.48%, ranking against industry peers normally.

Dividend Metrics

Valuation

Boston Scientific (BSX) at 18.04 sits in the cheaper P/E ratio quartile, while Encompass Health (EHC) at 22.01 is closer to its industry’s usual earnings multiple — a discount for BSX, though growth and earnings durability still matter.

On P/S ratio, both Boston Scientific (BSX) at 2.94 and Encompass Health (EHC) at 2.13 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

On P/B ratio, both Boston Scientific (BSX) at 2.42 and Encompass Health (EHC) at 5.04 are valued close to their industries’ norm against book — neither stands out from peers.

Valuation Metrics